DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Current Location:
>
>
> This Story

Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

U.S. Healthcare Homepage

QTC launches mobile medical clinic services

MITA commends new research paper demonstrating the many flaws of the medical device tax

AMA announces playbook to successfully adopt digital health

Philips Future Health Index shows U.S. is a leader in data collection, but falls short on satisfaction, trust and access

ASRT to donate $5,000 in support of Hurricane Michael relief efforts

CVS Health acquisition of Aetna moving forward on agreement with U.S. Department of Justice

ACR Commission on Patient- and Family-Centered Care announces new population health management committee

Quest Diagnostics launches the Global Diagnostics Network (GDN) to increase access to diagnostic insights worldwide

AdvaMed files amicus brief with Utah Supreme Court in Burningham v. Wright Medical

First robotic mastectomy performed for cancer in the United States by Dr. Stephen A. Chagares

AdvaMedDx applauds Hill's release of FDA’s technical assistance for legislation to modernize regulation of clinical diagnostics

Press releases may be edited for formatting or style
Washington, D.C. – AdvaMedDx applauds Capitol Hill's release of technical assistance (TA) developed by the Food and Drug Administration (FDA) to draft legislation authored by Representatives Larry Bucshon (R-IN) and Diana DeGette (D-CO) as a significant, positive step toward enacting legislation modernizing regulation of all diagnostics, including Laboratory Developed Tests (LDTs).

AdvaMedDx has long supported FDA oversight of all diagnostics, including LDTs, under a risk-based approach that promotes the public health and innovation.

Story Continues Below Advertisement

RaySafe helps you avoid unnecessary radiation

RaySafe solutions are designed to minimize the need for user interaction, bringing unprecedented simplicity & usability to the X-ray room. We're committed to establishing a radiation safety culture wherever technicians & medical staff encounter radiation.



“Innovative medical diagnostic tests and technologies are the foundation for evidence-based medicine, allowing for early intervention that improves patients' health outcomes, often lowering costs for the broader health system. The FDA’s technical assistance in support of a modernized and predictable, regulatory framework for all diagnostic tests, will allow further progress on Capitol Hill toward enacting legislation to speed the pace and reach of cutting edge diagnostics, allowing patients to benefit more broadly, rapidly, and confidently, from the latest diagnostic technologies," said Susan Van Meter, Executive Director of AdvaMedDx.

Over the past several years FDA has made strides to improve the regulatory process for diagnostics through flexible, efficient approaches to help pave the way for new advances, including personalized medicine. This TA is a step forward in efforts to advance a risk based approach to regulation of clinical diagnostics that promotes the public health and innovation.

Today AdvaMedDx joined several patient groups, laboratory and provider associations in sending a letter to the Chairmen and Ranking members of the Senate Committee on Health, Education, Labor & Pensions (HELP) and House Energy and Commerce Committee, appreciating the release of the FDA’s TA as an important and necessary next step in the pursuit of comprehensive legislative reform. We urge Congress to move swiftly to enact comprehensive diagnostics regulatory reform legislation. To view the full letter, click here.

“As we review the TA released by the FDA, we look forward to continuing to work with Congress, the FDA, and the broad range of stakeholders with whom we share the goal of making diagnostics reform a reality,” said Van Meter.


About AdvaMedDx
AdvaMedDx member companies produce innovative, high quality in vitro diagnostic tests that facilitate evidence-based medicine, improve quality of patient care, promote wellness, enable early detection of disease and can reduce overall health care costs. Functioning as an association within AdvaMed, AdvaMedDx is dedicated to the issues facing in vitro diagnostic companies in the United States and abroad.

Back to HCB News
  Pages: 1

U.S. Healthcare Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2018 DOTmed.com, Inc.
ALL RIGHTS RESERVED